Position in AKBA
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$13,680
-$8,560 QoQ
Shares Held
12,000
-25.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#131
of 170 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026WEALTH EFFECTS LLC holds $368,827 across 3 Drug Manufacturers - Specialty & Generic names. AKBA ranks #3 (3.7% of the industry book) .
All Filings in AKBA
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,680 | 12,000 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $22,240 | 16,000 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $25,760 | 16,000 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $43,680 | 16,000 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $125,580 | 34,500 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $61,440 | 32,000 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $60,800 | 32,000 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $35,640 | 27,000 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $27,540 | 27,000 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $49,410 | 27,000 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $36,580 | 29,500 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $33,630 | 29,500 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $16,759 | 18,316 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $10,256 | 18,316 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $10,568 | 18,316 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $5,787 | 18,316 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,465 | 18,316 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $13,518 | 18,828 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||